Allianz Asset Management’s Fusion Pharmaceuticals Inc. Common Shares FUSN Stock Holding History

Allianz Asset Management’s Portfolio FUSN Stock Details FUSN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-20,800	Closed	-$443K	–	2288
2024 Q1	$443K	Buy	+20,800	New	+$249K	﹤0.01%	1656

Allianz Asset Management's FUSN Position: Q2 2024 in Review

Allianz Asset Management sold out of Fusion Pharmaceuticals Inc. Common Shares (FUSN) in Q2 2024, closing a stake of 20,800 shares — an estimated $443K sold.

Allianz Asset Management first reported a position in FUSN in Q1 2024 and held it in 1 quarter. The position peaked at $443K in Q1 2024. 0 funds tracked by Wall St. Rank hold FUSN as of Q2 2024.

Allianz Asset Management reported no remaining Fusion Pharmaceuticals Inc. Common Shares position as of Q2 2024 after selling out during the quarter.
Allianz Asset Management sold 20,800 Fusion Pharmaceuticals Inc. Common Shares shares in Q2 2024, an estimated $443K.
Allianz Asset Management first reported a position in Fusion Pharmaceuticals Inc. Common Shares in Q1 2024 and held it in 1 quarter.
Allianz Asset Management's Fusion Pharmaceuticals Inc. Common Shares position peaked at $443K in Q1 2024.
0 funds tracked by Wall St. Rank held Fusion Pharmaceuticals Inc. Common Shares as of Q2 2024.

Based on Allianz Asset Management's 13F filing for Q2 2024, filed 13 Aug 2024.